This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Jan 20;391(10117):183-184.

doi: 10.1016/S0140-6736(17)32847-7. Epub 2017 Nov 10.

Antithrombotic therapy in peripheral artery disease

Jeffrey S Berger¹

Affiliations

Affiliation

¹ Department of Medicine (Cardiology and Hematology) and Surgery (Vascular Surgery), New York University School of Medicine, New York, NY 10016, USA. Electronic address: jeffrey.berger@nyumc.org.

PMID: 29132877
DOI: 10.1016/S0140-6736(17)32847-7

Comment

Antithrombotic therapy in peripheral artery disease

Jeffrey S Berger. Lancet. 2018.

. 2018 Jan 20;391(10117):183-184.

doi: 10.1016/S0140-6736(17)32847-7. Epub 2017 Nov 10.

Author

Jeffrey S Berger¹

Affiliation

¹ Department of Medicine (Cardiology and Hematology) and Surgery (Vascular Surgery), New York University School of Medicine, New York, NY 10016, USA. Electronic address: jeffrey.berger@nyumc.org.

PMID: 29132877
DOI: 10.1016/S0140-6736(17)32847-7

No abstract available

PubMed Disclaimer

Comment on

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators. Anand SS, et al. Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10. Lancet. 2018. PMID: 29132880 Clinical Trial.

Similar articles

Antithrombotic Therapy in Patients With Peripheral Artery Disease.
Bonaca MP. Bonaca MP. JAMA Cardiol. 2016 Oct 1;1(7):803-804. doi: 10.1001/jamacardio.2016.2797. JAMA Cardiol. 2016. PMID: 27571765 No abstract available.
Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
Tangelder MJ, van Hattum ES. Tangelder MJ, et al. Thromb Haemost. 2010 Aug;104(2):196-9. doi: 10.1160/TH10-02-0104. Epub 2010 May 27. Thromb Haemost. 2010. PMID: 20508897 No abstract available.
Antithrombotic therapy in peripheral artery disease.
Foley TR, Waldo SW, Armstrong EJ. Foley TR, et al. Vasc Med. 2016 Apr;21(2):156-69. doi: 10.1177/1358863X15622987. Epub 2016 Jan 28. Vasc Med. 2016. PMID: 26823456 Review.
Antithrombotic Therapy for Peripheral Artery Disease in 2018.
Hess CN, Hiatt WR. Hess CN, et al. JAMA. 2018 Jun 12;319(22):2329-2330. doi: 10.1001/jama.2018.5422. JAMA. 2018. PMID: 29860284 Review. No abstract available.
[Antithrombotic therapy in lower extremity arterial disease].
Franzese M, Coscioni E, Scalise M, Gerardi D, Giugliano G, Esposito G, Stabile E. Franzese M, et al. G Ital Cardiol (Rome). 2019 Nov;20(11):632-640. doi: 10.1714/3254.32224. G Ital Cardiol (Rome). 2019. PMID: 31697270 Review. Italian.

See all similar articles

Cited by

Advances in the treatment of atherosclerotic plaque based on nanomaterials.
Wang P, Chen W, Zhang J, Pan C, Lv Y, Sun Y, Wang Y, Ma X, Gao C, Chen T, Wu A, Zheng J. Wang P, et al. Nanomedicine (Lond). 2025 Apr;20(8):869-881. doi: 10.1080/17435889.2025.2480049. Epub 2025 Mar 20. Nanomedicine (Lond). 2025. PMID: 40109186 Review.
Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study.
Ji Y, Wang B, Wu G, Zhang Y, Wang Q, Zhou M. Ji Y, et al. Ther Adv Chronic Dis. 2023 Dec 6;14:20406223231213262. doi: 10.1177/20406223231213262. eCollection 2023. Ther Adv Chronic Dis. 2023. PMID: 38085917 Free PMC article.
Response to clopidogrel in patients undergoing lower extremity revascularization.
Tawil M, Maldonado TS, Xia Y, Berland T, Cayne N, Jacobowitz G, Lugo J, Lamparello P, Sadek M, Rockman C, Berger JS. Tawil M, et al. Vascular. 2023 Dec;31(6):1110-1116. doi: 10.1177/17085381221103417. Epub 2022 May 19. Vascular. 2023. PMID: 35590464 Free PMC article.
Is PAD a Hypercoagulable Disorder?
Smilowitz NR, Berger JS. Smilowitz NR, et al. Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):387-389. doi: 10.1161/ATVBAHA.120.315209. Epub 2020 Dec 23. Arterioscler Thromb Vasc Biol. 2021. PMID: 33356366 Free PMC article. No abstract available.
Enhanced Autophagy in GAB1-Deficient Vascular Endothelial Cells Is Responsible for Atherosclerosis Progression.
Qian X, Wang H, Wang Y, Chen J, Guo X, Deng H. Qian X, et al. Front Physiol. 2021 Feb 2;11:559396. doi: 10.3389/fphys.2020.559396. eCollection 2020. Front Physiol. 2021. PMID: 33584322 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information